J7999 HCPCS Level II code: Compounded drug, not otherwise classified
J7999 is the HCPCS code for “Compounded drug, not otherwise classified” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7999Compounded drug, not otherwise classified
Short description: Compounded drug, noc
HCPCS · United States
Notes for J7999
As CMS prints them, with any note J7999 takes from the headings above it.
Note
- CMS processing note 0205: PUB 100-4, CH 17, SEC 20.1.2.
Medicare details
The indicators CMS publishes with J7999 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 2016
Where J7999 sits
- 1J codesDrugs administered other than orally
- 2Active code J7999Compounded drug, not otherwise classified
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7999 mean?
J7999 is the HCPCS code for “Compounded drug, not otherwise classified” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7999?
CMS lists J7999’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7999
All J codesJ7683Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligramJ7684Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligramJ7685Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligramsJ7686Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mgJ7699Noc drugs, inhalation solution administered through dmeJ7799Noc drugs, other than inhalation drugs, administered through dmeJ8498Antiemetic drug, rectal/suppository, not otherwise specifiedJ8499Prescription drug, oral, non chemotherapeutic, nosJ8501Aprepitant, oral, 5 mgJ8502Injection, aprepitant (aponvie), 1 mgJ8510Busulfan; oral, 2 mgJ8515Cabergoline, oral, 0.25 mg